Understanding the effect of CagriSema, cagrilintide, and semaglutide on muscle health

Status

Not yet recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2025-522920-28-00

Enrollment

100

Registered

2026-03-06

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CCI, Obesity

None listed

Sex/Gender

All

Age

18 Years to No maximum

None listed

Source: EU CTIS · Data processed: Mar 7, 2026